71 related articles for article (PubMed ID: 469256)
1. The enzymatic nature of human c1r: a subcomponent of the first component of complement.
Andrews JM; Baillie RD
J Immunol; 1979 Sep; 123(3):1403-8. PubMed ID: 469256
[TBL] [Abstract][Full Text] [Related]
2. The role of C1 esterase inhibitor in the activation of C1r, a subcomponent of the first component of complement from human plasma.
Tamura Y; Okamura K; Otsuka A; Fujii S
J Biochem; 1976 Feb; 79(2):313-9. PubMed ID: 1270407
[TBL] [Abstract][Full Text] [Related]
3. The first component of complement. I. Purification and properties of native C1.
Medicus RG; Chapuis RM
J Immunol; 1980 Jul; 125(1):390-5. PubMed ID: 7381205
[TBL] [Abstract][Full Text] [Related]
4. Unconjugated bilirubin inhibits C1 esterase activity.
Arriaga SM; Basiglio CL; Mottino AD; Almará AM
Clin Biochem; 2009 Jun; 42(9):919-21. PubMed ID: 19150444
[TBL] [Abstract][Full Text] [Related]
5. Human alpha-thrombin inhibition by the highly selective compounds N-ethoxycarbonyl-D-Phe-Pro-alpha-azaLys p-nitrophenyl ester and N-carbobenzoxy-Pro-alpha-azaLys p-nitrophenyl ester: a kinetic, thermodynamic and X-ray crystallographic study.
De Simone G; Balliano G; Milla P; Gallina C; Giordano C; Tarricone C; Rizzi M; Bolognesi M; Ascenzi P
J Mol Biol; 1997 Jun; 269(4):558-69. PubMed ID: 9217260
[TBL] [Abstract][Full Text] [Related]
6. The structure and enzymic activities of the C1r and C1s subcomponents of C1, the first component of human serum complement.
Sim RB; Porter RR; Reid KB; Gigli I
Biochem J; 1977 May; 163(2):219-27. PubMed ID: 869924
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical and functional characterization of the C1r subunit of the first complement component.
Ziccardi RJ; Cooper NR
J Immunol; 1976 Feb; 116(2):496-503. PubMed ID: 814163
[TBL] [Abstract][Full Text] [Related]
8. Stoichiometry and sedimentation properties of the complex formed between the C1q and C1r2C1s2 subcomponents of the first component of complement.
Siegel RC; Schumaker VN; Poon PH
J Immunol; 1981 Dec; 127(6):2447-52. PubMed ID: 6975324
[TBL] [Abstract][Full Text] [Related]
9. Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.
Nardini M; Pesce A; Rizzi M; Casale E; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M
J Mol Biol; 1996 May; 258(5):851-9. PubMed ID: 8637015
[TBL] [Abstract][Full Text] [Related]
10. [Structure of the active center of subtilisin 72].
Kazanskaia NF; Kost OA
Biokhimiia; 1982 May; 47(5):834-41. PubMed ID: 7046815
[TBL] [Abstract][Full Text] [Related]
11. Purified proenzyme C1r. Some characteristics of its activation and subsequent proteolytic cleavage.
Arlaud GJ; Villiers CL; Chesne S; Colomb MG
Biochim Biophys Acta; 1980 Nov; 616(1):116-29. PubMed ID: 6254570
[TBL] [Abstract][Full Text] [Related]
12. A sensitive colorimetric method for the measurement of serum C1 inactivator using the substrate N-alpha-acetyl-L-lysine methyl ester.
Harpel PC
J Immunol; 1970 Apr; 104(4):1024-30. PubMed ID: 5429516
[No Abstract] [Full Text] [Related]
13. Inorganic supports coated with N-substituted polyacrylamides: application to biospecific chromatography of proteins.
Ivanov AE; Kozlov LV; Shojbonov BB; Zubov VP; Antonov VK
Biomed Chromatogr; 1991 Mar; 5(2):90-3. PubMed ID: 1868265
[TBL] [Abstract][Full Text] [Related]
14. Activation of human C1r: Western blot analysis reveals slow and dose-dependent activation.
Hosoi S; Borsos T
J Immunol; 1988 Sep; 141(5):1610-4. PubMed ID: 2842400
[TBL] [Abstract][Full Text] [Related]
15. Activation of C1r by proteolytic cleavage.
Ziccardi RJ; Cooper NR
J Immunol; 1976 Feb; 116(2):504-9. PubMed ID: 1249422
[TBL] [Abstract][Full Text] [Related]
16. Isolation and initial characterization of tumoricidal monokine(s) from the human monocytic leukemia cell line THP-1.
Armstrong CA; Klostergaard J; Granger GA
J Natl Cancer Inst; 1985 Jan; 74(1):1-9. PubMed ID: 3918210
[TBL] [Abstract][Full Text] [Related]
17. Further studies on the identification of the subcomponents of the first component of complement after affinity chromatography of human serum on IgG-sepharose.
Taylor PA; Fink S; Bing DH; Painter RH
J Immunol; 1977 May; 118(5):1722-7. PubMed ID: 858917
[TBL] [Abstract][Full Text] [Related]
18. Kinetic peculiarities of human tissue kallikrein: 1--substrate activation in the catalyzed hydrolysis of H-D-valyl-L-leucyl-L-arginine 4-nitroanilide and H-D-valyl-L-leucyl-L-lysine 4-nitroanilide; 2--substrate inhibition in the catalyzed hydrolysis of N alpha-p-tosyl-L-arginine methyl ester.
Sousa MO; Miranda TL; Maia CN; Bittar ER; Santoro MM; Figueiredo AF
Arch Biochem Biophys; 2002 Apr; 400(1):7-14. PubMed ID: 11913965
[TBL] [Abstract][Full Text] [Related]
19. C1 subcomponent complexes: basic and clinical aspects.
Laurell AB; Sjöholm AG
Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
